Results 161 to 170 of about 1,203,145 (219)
Some of the next articles are maybe not open access.
FOXG1 is overexpressed in hepatoblastoma
Human Pathology, 2007Bacterial artificial chromosome array comparative genomic hybridization analysis of hepatoblastomas reveals a deletion in the 14q12 locus in 12 of 16 cases. A high frequency of copy gain is seen on chromosomes 1q, 2, 5p, 8, and 20. Frequent deletions are also seen at 6q, 17q, and 1p with less frequent gains on 4p, 6p, and 19p.
Adekunle Michael, Adesina +6 more
openaire +2 more sources
The transience of transient overexpression
Nature Methods, 2013Much of what is known about mammalian cell regulation has been achieved with the aid of transiently transfected cells. However, overexpression can violate balanced gene dosage, affecting protein folding, complex assembly and downstream regulation. To avoid these problems, genome engineering technologies now enable the generation of stable cell lines ...
Gibson, Toby J +2 more
openaire +3 more sources
DNA Polymerase Theta (POLQ) is a DNA polymerase involved in error-prone translesion DNA synthesis (TLS) and error-prone repair of DNA double-strand breaks (DSBs).
Kazuo Tsuchiya +2 more
exaly +2 more sources
Cad Overexpression in Mammalian Cells
Clinical Biochemistry, 1997Hamster CAD is a multifunctional protein which catalyzes the first three enzymatic steps of de novo pyrimidine biosynthesis.1'2 The major catalytic domains of CAD are car-bamyl phosphate synthetase (CPSase) (EC 6.3.5.5), dihydroorotase (DHOase) (EC 3.5.2.3), and aspartate transcarbamylase (ATCase) (EC 2.1.3.2). The first enzyme of the pathway, carbamyl
Y, Qiu, J N, Davidson
openaire +2 more sources
Lentiviral Overexpression of miRNAs
2013Deregulation of microRNAs (miRNAs) has been attributed to almost any human disease analyzed to date. This calls for models and experimental strategies for functional analyses of miRNAs enabling miRNA overexpression or suppression in target cell and/or tissues.
Hannah, Zöllner +2 more
openaire +2 more sources
HER2 overexpression and cancer targeting
Seminars in Oncology, 2001Overexpression of the HER2/neu oncogene is a frequent molecular event in multiple human cancers including breast and ovarian cancer. Patients with breast cancer that overexpress HER2/neu have a poor prognosis, shorter relapse time, and low survival rate.
S C, Wang, M C, Hung
openaire +2 more sources

